Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 wherein: X? is an anion with a single negative charge; and (b) a betamimetic 2, or a solvate or hydrate thereof, optionally in the form of the enantiomers, mixtures of the enantiomers, or in the form of the racemates thereof, processes for preparing them and their use in the treatment of respiratory complaints.

Abstract: A pharmaceutical composition comprising: (a) an anticholinergic of formula 1 wherein X? is an anion with a single negative charge; (b) a corticosteroid; and (c) a betamimetic, wherein each component (a), (b), and (c) are optionally in the form of the solvates or hydrates thereof, processes for preparing them, and their use in the treatment of respiratory diseases.

Abstract: An improved rotating latch connector system is disclosed wherein a connector assembly of the connector system includes on or more improvements such as connector lugs having a narrow width chamfered edges, or an asymmetric apex. Improvements to the receptacle assembly may include a modified two-stage entry cone, placement of one or more anti-rotation barriers within the receptacle assembly and modifications to the receptacle lugs similar to those described for the connector lugs.

Abstract: A floating offshore platform, of the type having a buoyancy can disposed within a support structure, includes a can guide assembly that has at least two compliant compression pads that are configured and arranged to provide a non-linear load-versus-deflection characteristic in response to impact loads generated by the impact of the can against the guide assembly. At least one of the compression pads is substantially stiffer (less compliant) than the other pad. The pads are arranged so that the relatively soft pad absorbs the impact load before the relatively stiff pad is engaged. In one embodiment, first, second, and third compression pads are arranged vertically, the upper and lower pads being softer (more compliant) than the middle pad. In another embodiment, a first, relatively soft, compression pad coaxially surrounds a second, relatively stiff compression pad.

Abstract: A pharmaceutical composition comprising: (a) a salt of formula 1 ?wherein: X? is an anion with a single negative charge; and (b) a steroid 2, processes for preparing such pharmaceutical composition, and their use in the treatment of respiratory complaints.

Abstract: A floating offshore platform, of the type having a buoyancy can disposed within a support structure, includes a can guide assembly that has at least two compliant compression pads that are configured and arranged to provide a non-linear load-versus-deflection characteristic in response to impact loads generated by the impact of the can against the guide assembly. At least one of the compression pads is substantially stiffer (less compliant) than the other pad. The pads are arranged so that the relatively soft pad absorbs the impact load before the relatively stiff pad is engaged. In one embodiment, first, second, and third compression pads are arranged vertically, the upper and lower pads being softer (more compliant) than the middle pad. In another embodiment, a first, relatively soft, compression pad coaxially surrounds a second, relatively stiff compression pad.

Abstract: The invention relates to novel medicament compositions based on anticholinesterase drugs and on ciclesonides, to methods for the production thereof, and to their use in treating respiratory tract diseases.

Abstract: A pharmaceutical composition comprising:

Abstract: A pharmaceutical composition comprising a tiotropium salt; and an antihistamine, optionally together with a pharmaceutically acceptable excipient, the tiotropium salt and the antihistamine optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.

Abstract: A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.

Abstract: A guide for a buoyancy can on a floating offshore platform. The platform includes at least one support structure adjacent the buoyancy can. The guide comprises at least one compression pad supported by the support structure and adjacent the exterior surface of the buoyancy can. Lateral movement of the buoyancy can toward the support structure compresses the compression pad so as to absorb the force generated by the buoyancy can movement, and so as to protect the buoyancy can and components of the floating offshore platform from damage.

Abstract: A pharmaceutical composition comprising:

Abstract: The present invention relates to novel pharmaceutical compositions based on a new anticholinergic 1 and heterocyclic compounds 2, processes for preparing them and their use in the treatment of respiratory complaints.

Abstract: A pharmaceutical composition comprising:

Abstract: A method for treating an inflammatory or obstructive disease of the respiratory tract which comprises administering therapeutically effective amounts of both an anticholinergic and a compound of the formula (2) 1

Abstract: A process for nebulizing highly concentrated solutions of insulin for administration by inhalation.

Abstract: There is provided a guide for a buoyancy can on a floating offshore platform. The platform includes at least one support structure adjacent the buoyancy can. The guide comprises at least one compression pad supported by the support structure and adjacent the exterior surface of the buoyancy can. Lateral movement of the buoyancy can toward the support structure compresses the compression pad so as to absorb the force generated by the buoyancy can movement, and so as to protect the buoyancy can and components of the floating offshore platform from damage.

Abstract: New imidazotriazolopyrimidine derivatives of the formula Preferred are those compounds wherein: R1 denotes methyl, which is optionally substituted by phenyloxy or pyrrole; or R1 denotes benzyl which is optionally substituted by hydroxy, methoxy, dimethylaminoethoxy or fluorine; or R1 denotes cyclopentyl, furan or phenylethyl; R2 or R3 denote ethyl, n-propyl, allyl or propargyl; R4 or R6 denote hydrogen; and, R5 denotes methyl, n-propyl, tert.butyl, cyclopentyl or norbornenyl. These are adenosine antagonists are are useful for, inter alia, the treatment of senile dementia of the Alzheimer's type.

Abstract: A pharmaceutical composition comprising an anticholinergic and a steroid, optionally together with a pharmaceutically acceptable excipient, the anticholinergic and the steroid optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.

Abstract: A pharmaceutical composition comprising a tiotropium salt; and an antihistamine, optionally together with a pharmaceutically acceptable excipient, the tiotropium salt and the antihistamine optionally in the form of their enantiomers, mixtures of their enantiomers, their racemates, their solvates, or their hydrates, processes for preparing them, and their use in the treatment of respiratory tract diseases.